Skip to main content

Table 1 Background data for the 75-year old study participants (n = 154).

From: Prevalence of abnormal glucose metabolism in atrial fibrillation: A case control study in 75-year old subjects

  Atrial fibrillation No atrial fibriallation Chi-square/df/p or t/d.f/p
Gender (male/female) 34 (31.8%)/12 (25.5%) 73 (68.2%)/35 (74.5%) 0.608/1/0.44
BMI (kg/m2) 25.3 ± 3.7 25.4 ± 3.2 -0.176/145/0.86
Waist (cm) 93.5 ± 11.7 91.6 ± 10.9 0.936/151/0.35
SBP (mmHg) 143 ± 21 147 ± 16 -1.169/152/0.24
DBP (mmHg) 82 ± 10 81 ± 9 1.069/152/0.29
Concomitant disorders, n (%)
Hypertension 38 (82.6%) 83 (76.9%) 0.635/1/0.43
MI 6 (13.0%) 11 (10.2%) 0.268/1/0.60
HF 7 (15.2)* 0 (0.0%) < 0.001 (Fisher)
Valve surgery 3 (6.5%)* 1 (0.9%) 0.046 (Fisher)
CABG/PCI 6 (13.0%) 8 (7.4%) 1.240/1/0.27
Cerebrovascular disease 5 (10.9%)* 2 (1.9%) 0.025 (Fisher)
Medication, n (%)
Warfarin 33 (76.1%)* 4 (3.7%) < 0.001 (Fisher)
Acetylic acid 3 (6.5%) 33 (30.6%)* 0.001 (Fisher)
Digitoxin 8 (17.4)* 0 (0%) < 0.001 (Fisher)
Verapamil 10 (21.7)* 2 (1.9) < 0.001 (Fisher)
Other Ca2+ blockers 4 (8.7) 11 (8.7) 1.000 (Fisher)
Beta blockers 14 (30.4%)* 16 (14.8%) 5.018/1/0.03*
ACE inhibitor 12 (26.1%)* 13 (12.0%) 4.683/1/0.03*
AT-II antagonist 13 (28.3%)* 13 (12.0%) 6.051/1/0.01*
Diuretics 12 (26.1%)* 5 (4.6%) 15.125/1/<0.001*
Statins 18 (39.1)* 19 (17.6) 8.198/1/0.01*
Laboratory parameters
Total leukocyte count (109) 6.0 ± 1.3 6.2 ± 1.6 -0.52/140/0.61
Creatinine (μmol/l) 84 ± 21 80 ± 23 0.93/137/0.35
Total cholesterol (mmol/l) 5.2 ± 1.0* 5.6 ± 1.1 -2.326/140/0.02*
Triglycerides (mmol/l) 1.1 ± 0.8 1.1 ± 0.6 0.162/140/0.87
HDL-cholesterol (mmol/l) 1.7 ± 0.6 1.7 ± 0.5 0.443/140/0.66
LDL-cholesterol (mmol/l) 2.9 ± 0.9* 3.4 ± 1.0 -2.713/139/0.01
  1. *: p ≤ 0.05. Abbreviations: BMI – body mass index, SBP – systolic blood pressure, DBP – diastolic blood pressure, MI – myocardial infarction, HF – heart failure, CABG – coronary artery by-pass graft, PCI – percutaneous coronary intervention, Ca2+-calcium, ACE – angiotensin converting enzyme, AT-II – angiotensin II, HDL – high density lipoprotein, LDL – low density lipoprotein.